Aggarwal et al., 2004: Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S. & Takada, Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res., 24, 2783–2840, 2004.

Aggarwal et al., 2003: Aggarwal, B. B., Kumar, A. & Bharti, A. C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res., 23, 363–398, 2003.

Alani et al., 1999: Alani, R. M., Hasskarl, J., Grace, M., Hernandez, M. C., Israel, M. A. & Munger, K. Immortalization of primary human keratinocytes by the helix–loop–helix protein, Id-1. Proc. Natl. Acad. Sci. USA, 96, 9637–9641, 1999.

Almond & Cohen, 2002: Almond, J. B. & Cohen, G. M. The proteasome: a novel target for cancer chemotherapy. Leukemia, 16, 433–443, 2002.

Angel et al., 1988: Angel, P., Hattori, K., Smeal, T. & Karin, M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell, 55, 875–885, 1988.

Angel et al., 1987: Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P. & Karin, M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell, 49, 729–739, 1987.

Arbiser et al., 1998: Arbiser, J. L., Klauber, N., Rohan, R., van Leeuwen, R., Huang, M. T., Fisher, C.,Flynn, E. & Byers, H. R. Curcumin is an in vivo inhibitor of angiogenesis. Mol. Med., 4, 376–383, 1998.

Arora et al., 1971: Arora, R. B., Kapoor, V., Basu, N. & Jain, A . P. Anti-inflammatory studies on Curcuma longa (turmeric). Indian J. Med. Res., 59, 1289–1295, 1971.

Battistutta et al., 2000: Battistutta, R., Sarno, S., De Moliner, E., Papinutto, E., Zanotti, G. & Pinna, L.A. The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2. J. Biol. Chem., 275, 29618–29622, 2000.

Bech-Otschir et al., 2001: Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C. & Dubiel, W. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J., 20, 1630–1639, 2001.

Bech-Otschir et al., 2002: Bech-Otschir, D., Seeger, M. & Dubiel, W. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J. Cell. Sci., 115, 467–473, 2002.

Benezra et al., 1990: Benezra, R., Davis, R., Lockshon, D., Turner, D. & Weintraub, H. The protein ID – a negative regulator of helix-loop-helix DNA binding proteins. Cell, 61, 49–59, 1990.

Benezra et al., 2001: Benezra, R., Raffi, S. & Lyden, D. The Id proteins and angiogenesis. Oncogene, 20, 8334–8341, 2001.

Berse et al., 2004: Berse, M., Bounpheng, M., Huang, X., Christy, B., Pollmann, Ch . & Dubiel, W. Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. J. Mol. Biol., 343, 361–370, 2004.

Bianchi et al., 2003: Bianchi, E., Denti, S., Catena, R., Rossetti, G., Polo, S., Gasparian, S., Putignano, S., Rogge, L. & Pardi, R. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity. J. Biol. Chem., 278, 19682–19690, 2003.

Bounpheng et al., 1999: Bounpheng, M. A., Dimas, J. J., Dodds, S. G. & Christy, B. A. Degradation of Id proteins by the ubiquitin-proteasome pathway. FASEB J., 13, 2257–2264, 1999.

Bouvet et al., 1998: Bouvet, M., Bold, R. J., Lee, J., Evans, D. B., Abbruzzese, J. L., Chiao, P. J., McConkey, D. J., Chandra, J., Chada, S., Fang, B., & Roth, J. A. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer. Ann. Surg. Oncol., 5, 681–688, 1998.

Brooks et al., 2000: Brooks, P., Fuertes, G., Murray, R. Z., Bose, S., Knecht, E., Rechsteiner, M. C., Hendil, K. B., Tanaka, K., Dyson, J. & Rivett, A. J. Subcellular localization of proteasomes and their regulatory complexes in mammalian cells. Biochem. J., 346, 155–161, 2000.

Bussolino et al ., 1997: Bussolino, F., Mantovani, A. & Persico, G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci., 22, 251–256, 1997.

Chen & Tan, 1998: Chen, Y.R. & Tan, T. H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene, 17, 173–178, 1998.

Christy et al., 1991: Christy, B. A., Sanders, L. K., Lau, L. F., Copeland, N. G., Jenkins, N. A. & Nathans, D. An ID-related helix-loop-helix protein encoded by a growth factor inducible gene. Proc. Natl. Acad. Sci. USA, 88, 1815–1819., 1991.

Ciechanover, 1994: Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell, 79, 13–21, 1994.

Claret et al., 1996: Claret, F. X., Hibi, M., Dhut, S., Toda, T. & Karin, M. A new group of conserved coactivators that increase the specifity of AP-1 transcription factors. Nature, 383, 453–457, 1996.

Cohen et al., 2000: Cohen, H., Azriel, A., Cohen, T., Meraro, D., Hashmueli, S., Bech-Otschir, D., Kraft, R., Dubiel, W. & Levi, B. Z. Interaction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15). A possible link between interferon regulatory factor signaling and the COP9/signalosome. J. Biol. Chem., 275, 39081–39089, 2000.

Cope et al., 2002: Cope, G. A., Suh, G. S., Aravind, L., Schwarz, S. E., Zipursky, S. L., Koonin, E. V. & Deshaies, R. J. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science, 298, 608–611, 2002.

de Candia et al., 2003: de Candia, P., Solit, D. B., Giri, D., Brogi, E., Siegel, P. M., Olshen, A. B., Muller, W. J., Rosen, N. & Benezra, R. Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc. Natl. Acad. Sci. USA, 100, 12337–12342, 2003.

Deed et al., 1996: Deed, R. W., Armitage, S. & Norton, J. D. Nuclear localization and regulation of Id protein through an E protein-mediated chaperone mechanism. J. Biol. Chem., 271, 23603–23606, 1996.

Deed et al., 1997: Deed, R. W., Hara, E., Atherton, G. T., Peters, G. & Norton, J. D. Regulation of ID3 cell cycle function by Cdk2-dependent phosphorylation. Mol. Cell Biol., 17, 6815–6821, 1997.

Deshaies, 1999: Deshaies, R. J. SCF and Cullin/Ring H2-based ubiquitinligases. Annu. Rev. Cell Dev. Biol., 15, 435–467, 1999.

Desprez et al., 1998: Desprez, P-Y., Lin, C. Q., Thomasset, N., Sympson, C. J., Bissell, M. J. & Campisi, J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein, ID1. Mol. Cell Biol., 18, 4577–4588, 1998.

Devary et al., 1991: Devary, Y., Gottlieb, R. A., Lau, L. & Karin, M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol., 11, 2804–2811, 1991.

Dunn et al., 2002: Dunn, C., Wiltshire, C., MacLaren, A. & Gillespie, D. A. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal., 14, 585–593, 2002.

Eferl & Wagner, 2003: Eferl, R. & Wagner, E. F. AP-1: A double-egded sword in tumorigenesis. Nat. Rev. Cancer, 3, 859–868, 2003.

Fajerman et al., 2004: Fajerman, I., Schwartz, A. L. & Ciechanover, A . Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. Biochem. Biophys. Res. Commun., 314, 505–512, 2004.

Fang & Kerppola, 2004: Fang, D. & Kerppola, T. K. Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. PNAS, 101, 14782–14787, 2004.

Fang et al., 2002: Fang, D., Elly, C., Gao, B., Fang, N., Altman, Y., Joazeiro, C., Hunter, T., Copeland, N., Jenkins, N. & Liu, Y. C. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat. Immunol., 3, 281–287, 2002.

Ferrara, 2002: Ferrara, N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev. Cancer, 2, 795–803, 2002.

Ferrara, 2001: Ferrara, N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol., 280, C1358–C1366, 2001.

Ferrara & Henzel, 1989: Ferrara, N. & Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Comm., 161, 851–858, 1989.

Ferrara et al., 2003: Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med., 9, 669–676, 2003.

Folkman & Klagsbrun, 1987: Folkman, J. & Klagsbrun, M. Angiogenic factors. Science, 235, 442–447, 1987.

Freilich et al., 1999: Freilich, S., Oron, E., Kapp, Y., Nevo-Caspi, Y., Orgad, S., Segal, D. & Chamovitz, D.A. The COP9 signalosome is essential for development of Drosophila melanogaster. Curr. Biol., 9, 1187–1190, 1999.

Fu et al., 2001: Fu, H., Reis, N., Lee, Y., Glickman, M. H. & Vierstra, R. D. Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J., 20, 7096–7107, 2001.

Fuchs et al., 1996: Fuchs, S. Y., Dolan, L., Davis, R. J. & Ronai, Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene, 13, 1531–1535, 1996.

Glickman et al., 1998: Glickman, M.H., Rubin, D.M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Baumeister, W., Fried, V.A. & Finley, D. A. subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9 signalosome and eIF3. Cell, 94, 615–623, 1998.

Goldberg, 2003: Goldberg, A. L. Protein degradation and protection against misfolded or damaged proteins. Nature, 426, 895–899, 2003.

Groisman et al., 2003: Groisman, R., Polanowska, J., Kuraoka, I., Sawada, J., Saijo, M., Drapkin, R., Kisselev, A.F., Tanaka, K., & Nakatani, Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell, 113, 357–367, 2003.

Guerra & Issinger, 1999: Guerra, B. & Issinger, O. G. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis, 20, 391–408, 1999.

Gupta & Qin, 2003: Gupta, M. K. & Qin, R. Y. Mechanism and its regulation of tumor-induced angiogenesis. World J. Gastroenterol., 9, 1144–1155, 2003.

Hall et al., 2004: Hall, M. C., Warren, E. N. & Borchers, C. H. Multi-kinase phosphorylation of the APC/C activator Cdh1 revealed by mass spectrometry. Cell Cycle, 3, 1278–1284, 2004.

Hara et al., 1997: Hara, E., Hall, M. & Peters, G. Cdk2-dependent phosphorylation of ID2 modulates activity of E2A-related transcription factors. EMBO J., 16, 101–110, 1997.

Hara et al., 1994: Hara, E., Yamaguchi, T., Nojima, H., Ide, T., Campisi, J., Okayama, H. & Oda, K. Id-related genes encoding HLH proteins are required for G1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem., 269, 2139–2145, 1994.

Harari-Steinberg & Chamovitz, 2004: Harari-Steinberg, O. & Chamovitz, D. A. The COP9 signalosome: Mediating Between Kinase Signaling and Protein Degradation. Curr. Protein Pept. Sci., 5, 185–189, 2004.

Hardtke et al., 2000: Hardtke, C.S., Gohda, K., Osterlund, M.T., Oyama, T., Okada, K. & Deng, X.W. HY5 stability and activity in arabidopsis is regulated by phosphorylation in its COP1 binding domain. EMBO J., 19, 4997–5006, 2000.

Hasmeda & Polya, 1996: Hasmeda, M. & Polya, G. M. Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry, 42, 599–605, 1996.

Haworth & Avkiran, 2001: Haworth, R.S. & Avkiran, M. Inhibition of protein kinase D by resveratrol. Biochem. Pharmacol., 62, 1647–1651, 2001.

Hayami et al., 2005: Hayami, R., Sato, K., Wu, W., Nishikawa, T., Hiroi, J., Ohtani-Kaneko, R., Fukuda, M. & Ohta, T. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2. Cancer Res., 65, 6–10, 2005.

Henke et al., 1999: Henke, W., Ferrell, K., Bech-Otschir, D., Seeger, M., Schade, R., Jungblut, P., Naumann, M. & Dubiel, W. Comparison of human COP9 signalsome and 26S proteasome lid. Mol. Biol. Rep., 26, 29–34, 1999.

Henry et al., 2003: Henry, T. D., Annex, B. H., McKendall, G. R., Azrin, M. A., Lopez, J. J., Giordano, F. J., Shah, P. K., Willerson, J. T., Benza, R. L., Berman, D. S., Gibson, C. M., Bajamonde, A., Rundle, A. C., Fine, J. & McCluskey, E. R. The VIVA trial: Vascular endothilial growth factor in ischemia for vascular angiogenesis. Circulation, 107, 1359–1365, 2003.

Hershko, 1997: Hershko A. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell. Biol., 9, 788–799, 1997.

Hershko & Ciechanover, 1998: Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem., 67, 425–479, 1998.

Hill et al., 1994: Hill, C. S., Wynne, J. & Treisman, R. Serum-regulated transcription by serum response factor (Srf) - a novel role for the DNA binding domain. EMBO J., 13, 5421–5432, 1994.

Huang et al., 1992: Huang, H. C., Chang, J. H., Tung, S. F., Wu, R. T., Foegh, M. L. & Chu, S. H. Immunosuppressive effect of emodin, a free radical generator. Eur. J. Pharmacol., 211, 359–364, 1992.

Huang et al., 1994: Huang, M. T., Lou, Y. R., Ma, W., Newmark, H. L., Reuhl, K. R. & Conney, A. H. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res., 54, 5841–5847, 1994.

Iavarone et al., 1994: Iavarone, A., Garg, P., Lasorella, A., Hsu, J. & Israel, M. A. The helix-loop-helix protein ID2 enhances cell proliferation and binds to the Retinoblastoma protein. Genes and Dev., 8, 1270–1284, 1994.

Johnson et al., 1996: Johnson, S. E. ,Wang , X., Hardy, S., Taparowsky, E. J. & Konieczny, S. F. Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol. Cell. Biol., 16, 1604–1613, 1996.

Kalebic et al., 1983: Kalebic, T., Garbisa, S., Glaser, B. & Liotta, L. A. Basement membrane collagen: degradation by migrating endothelial cells. Science, 221, 281–283, 1983.

Kapelari et al., 2000: Kapelari, B., Bech-Otschir, D., Hegerl, R., Schade, R., Dumdey, R. & Dubiel, W. Electron microscopy and subunit-subunit interactionstudies reveal a first architecture of COP9 signalosome. J. Mol. Biol., 300, 1169–1178, 2000.

Karin, 1995: Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270, 16483–16486, 1995.

Karin & Ben-Neriah, 2000: Karin, M. & Ben-Neriah, Y . Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol., 18, 621-663, 2000.

Kerbel & Folkman, 2002: Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer, 2, 727–739, 2002.

Kim et al., 2003: Kim, J. H., Park, K. C., Chung, S. S., Bang, O. & Chung, C. H. Deubiquitinating enzymes as cellular regulators. J Biochem , 134, 9–18, 2003.

Krzystolik et al., 2002: Krzystolik, M. G., Afshari, M. A., Adamis, A. P., Gaudreault, J., Gragoudas, E. S., Michaud, N. A., Li, W., Connolly, E., O'Neill, C. A. & Miller, J. W. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch. Ophthalmol., 120, 338– 346 , 2002.

Kwok et al., 1999: Kwok, S. F., Staub, J. M. & Deng, X. W. Characterization of two subunits of Arabidopsis 19S proteasome regulatory complex and its possible interaction with the COP9 complex. J. Mol. Biol., 285, 85–95, 1999.

Lamph et al., 1988: Lamph, W. W., Wamsley, P., Sassone-Corsi, P. & Verma, I. M. Induction of the oncogene jun/AP-1 by serum and TPA. Nature, 334, 629–631, 1988.

Lasorella et al., 2000: Lasorella, A., Noseda, M., Beyna, M., Yokota, Y. & Iavarone, A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature, 407, 592–598, 2000.

Lasorella et al., 2001: Lasorella, A., Uo, T. & Iavarone, A. Id proteins at the cross-road of development and cancer. Oncogene, 20, 8326–8333, 2001.

LeCouter et al., 2001: LeCouter, J., Kowalski, J., Foster, J., Hass, P., Zhang, Z., Dillard-Telm, L., Frantz, G., Rangell, L., DeGuzman, L., Keller, G. A., Peale, F., Gurney, A., Hillan, K. J. & Ferrara, N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature, 412, 877–884, 2001.

Lee, 2001: Lee, H. Z. Effects and mechanisms of emodin on cell death in humanlung squamous cell carcinoma. Br. J. Pharmacol., 134, 11–20, 2001.

Lee et al., 1987a: Lee, W., Haslinger, A., Karin, M. & Tjian, R. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature, 325, 368–372, 1987.

Lee et al., 1987b: Lee, W., Mitchell, P. & Tjian, R. Purified transcription factor AP- 1 interacts with TPA-inducible enhancer elements. 1987, 49, 741–752, Cell.

Levy et al., 1995: Levy, A. P., Levy, N. S., Wegner, S. & Goldberg, M. A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem., 270, 13333–13340, 1995.

Li et al., 2004: Li, H., Gerald, W. L. & Benezra, R. Utilization of Bone Marrow-Derived Endothelial Cell Precursors in Spontaneous Prostate Tumors Varies with Tumor Grade. Cancer Res., 64, 6137–6143, 2004.

Lin et al., 2000: Lin, C. Q., Singh, J., Murata, K., Itahana, Y., Parrinello, S., Liang, S. H., Gillet, C. E., Campisi, J. & Desprez, P-Y. A role for ID1 in the aggressive phenotype and steroid response of human breast cancer cells. Cancer Res., 60, 1332–1340, 2000.

Lluis et al., 2005: Lluis, F., Ballestar, E., Suelves, M., Esteller, M. & Munoz-Canoves, P. E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J. , 24, 974–984, 2005.

Longo et al ., 2002: Longo, R., Sarmiento, R., Fanelli, M., Capaccetti, B., Gattuso, D. & Gasparini, G. Anti-angiogenic therapy: Rationale, challenges and clinical studies. Angiogenesis, 5, 237–256, 2002.

Lyapina et al ., 2001: Lyapina, S., Cope, G., Shevchenko, A., Serino, G., Tsuge, T., Zhou, C., Wolf, D. A., Wei, N. & Deshaies, R. J. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science, 292, 1382–1385, 2001.

Lyden et al ., 2001: Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn,A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N. R., Crystal, R. G., Moore, M. A. S., Hajjar, K. A., Manova, K., Benezra, R. & Rafii, S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med., 7, 1194–1201, 2001.

Lyden et al ., 1999: Lyden, D., Young, E. Z., Zagzag, D., Yan, W., Gerald, W., O´Reilly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., Manova, K. & Benezra, R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401, 670–677, 1999.

Makinen et al., 2002: Makinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E. & Yla-Herttuala, S. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol. Ther., 6, 127–133, 2002.

Malterud et al., 1993: Malterud, K. E., Farbrot, T. L., Huse, A. E. & Sund, R. B. Antioxidantand radical scavenging effects of anthraquinones and anthrones. Pharmacology, 47 (Suppl. 1), 77–85, 1993.

Massari & Murre, 2000: Massari, M. E. & Murre, C. Helix-loop-lelix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol., 20, 429–440, 2000.

McNamara et al., 1998: McNamara, D. A., Harmey, J. H., Walsh, T. N., Redmond, H. P. & Bouchier-Hayes, D. J. Significance of angiogenesis in cancer therapy. Br. J. Surg., 85, 1044–1055, 1998.

Mullally & Fitzpatrick, 2002: Mullally, J. E. & Fitzpatrick, F. A. Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol. Pharmacol., 62, 351–358, 2002.

Mundt et al., 1999: Mundt, K.E., Porte, J., Murray, J.M., Brikos, C., Christensen, P.U., Caspari, T., Hagan, I.M., Millar, J.B., Simanis, V., Hofmann, K. & Carr, A.M. The COP9/signalosome complex is conserved in fission yeast and has a role in S phase. Curr. Biol., 9, 1427–1430, 1999.

Musti et al., 1997: Musti, A. M., Treier, M. & Bohmann, D Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science, 275, 400–402, 1997.

Nagata et al., 1995: Nagata, Y., Shoji, W., Obinata, M. & Todokoro, K. Phosphorylation of helix-loop-helix proteins ID1, ID2 and ID3. Biochem. Biophys. Res. Commun. , 207, 916–926, 1995.

Nateri et al., 2004: Nateri, A. S., Riera-Sans, L., Da Costa, C. & Behrens, A. The Ubiquitin Ligase SCFFbw7 Antagonizes Apoptotic JNK Signaling. Science, 303, 1374–1378, 2004.

Naumann et al., 1999: Naumann, M., Bech-Otschir, D., Huang, X., Ferrell, K. & Dubiel, W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J. Biol. Chem., 274, 35297–35300, 1999.

Neufeld et al., 1999: Neufeld, G., Cohen, T., Gengrinovitch, S. & Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13, 9–22, 1999.

Nordgard et al., 2001: Nordgard, O., Dahle, O., Andersen, T. O. & Gabrielsen, O. S. JAB1/CSN5 interacts with the GAL4 DNA binding domain: a note of caution about two-hybrid interactions. Biochimie, 83, 969–971, 2001.

Norton, 2000: Norton, J. D. ID proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci., 113, 3897–3905, 2000.

Norton et al., 1998: Norton, J. D., Craggs, G., Deed, R. W. & Sablitzky, F. ID helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol., 8, 58–65, 1998.

Norton & Atherton, 1998: Norton, J.D. & Atherton, G.T. Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell. Biol., 18, 2371–2381, 1998.

O´Toole et al., 2003: O´Toole, P. J., Inoue, T., Emerson, L., Morrison, I. E., Mackie, A. R., Cherry, R. J. & Norton, J. D. Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization. J. Biol. Chem., 278, 45770–45776, 2003.

Ohtani et al., 2001: Ohtani, N., Zebedee, Z., Huot, T. J., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G. & Hara, E. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence . Nature, 409, 1067–1070, 2002.

Osterlund et al., 1999: Osterlund, M. T., Ang, L. H. & Deng, X. W. The role of COP1 in repression of Arabidopsis photomorphogenic development. Trends Cell Biol., 9, 113–118, 1999.

Osterlund et al., 2000: Osterlund, M. T., Hardtke, C. S., Wei, N. & Deng, X. W. Targeted destabilization of HY5 during light-regulated development of Arabidopsis. Nature, 405, 462–466, 2000.

Park et al., 1998: Park, S., Lee, D. K. & Yang, C. H. Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett., 127, 23–28, 1998.

Peng et al., 2003: Peng, Z., Shen, Y., Feng, S., Wang, X., Chitteti, B. N., Vierstra,R. D. & Deng, X. W. Evidence for a physical association of the COP9 signalosome, the proteasome, and specific SCF E3 ligases in vivo. Curr. Biol., 13, R504–R505, 2003.

Pickart, 2001: Pickart, C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem., 70, 503–533, 2001.

Pollmann et al., 2001: Pollmann, C., Huang, X., Mall, J., Bech-Otschir, D., Naumann, M. & Dubiel, W. The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells. Cancer Res., 61, 8416–8421, 2001.

Prabhu et al., 1997: Prabhu, S., Ignatova, A., Park, S. T. & Sun, X-H. Regulation of expression of the cyclin dependent kinase inhibitor p21 by E2A and ID proteins. Mol. Cell Biol., 17, 5888–5896, 1997.

Pray et al., 2002: Pray, T. R., Parlati, F., Huang, J., Wong, B. R., Payan, D. G., Bennett, M. K., Issakani, S. D., Molineaux, S. & Demo, S. D. Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist. Updat., 5, 249–258, 2002.

Reddy & Lokesh, 1994: Reddy, A. C. & Lokesh, B. R. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol. Cell. Biochem., 137, 1–8, 1994.

Riechmann et al., 1994: Riechmann, V., van Cruchten, I. & Sablitzky, F. The expression pattern of Id4, a novel dominant negative helix-loop-helix protein is distinct from Id1, Id2 and Id3. Nucleic Acids Res., 22, 749–755, 1994.

Ruzinova & Benezra, 2003: Ruzinova, M. B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol., 13, 410–418, 2003.

Ruzinova et al., 2003: Ruzinova, M. B., Schoer, R. A., Gerald, W., Egan, J. E., Pandolfi, P. P., Rafii, S., Manova, K., Mittal, V., & Benezra, R. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell, 4, 277–289, 2003.

Sajithlal et al., 1998: Sajithlal, G. B., Chithra, P. & Chandrakasan, G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol., 56, 1607–1614, 1998.

Sakurai et al., 2004: Sakurai, D., Tsuchiya, N., Yamaguchi, A., Okaji, Y., Tsuno, N. H., Kobata, T., Takahashi, K., & Tokunaga, K. Crucial Role of Inhibitor of DNA Binding/Differentiation in the Vascular Endothelial Growth Factor-Induced Activation and Angiogenic Processes of Human Endothelial Cells. J. Immunol., 173, 5801–5809, 2004.

Scheffner et al., 1993: Scheffner, M., Huibregtse, J. M., Vierstra, R. D. & Howley, P. M. The HPV-16 E6 und E6-AP complex functions as a ubiquitin-protein ligase complex in the ubiquitination of p53. Cell, 75, 495–505, 1993.

Schwechheimer et al., 2001: Schwechheimer, C., Serino, G., Callis, J., Crosby, W. L., Lyapina,S., Deshaies, R. J., Gray, W. M., Estelle, M. & Deng, X. W. Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIRI in mediating auxin response. Science, 292, 1379–1382, 2001.

Seeger et al., 1998: Seeger, M., Kraft, R., Ferrell, K., Bech-Otschir, D., Dumdey, R., Schade, R. & Dubiel, W. A noval protein complex involved in signal transduction possessing similarities to 26 S proteasome subunits. FASEB J., 12, 469–478, 1998.

Senger et al., 1983: Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. & Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983–985, 1983.

Shaulian & Karin, 2001: Shaulian, E. & Karin, M. AP-1 in cell proliferation and survival. Oncogene, 20, 2390–2400, 2001.

Shaulian & Karin, 2002: Shaulian, E. & Karin, M. AP-1 as a regulator of cell life and death. Nat. Cell Biol., 4, E131–E136, 2002.

Shaulian et al., 2000: Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F. & Karin, M. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell, 103, 897–907, 2000.

Shweiki et al., 1992: Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843–845, 1992.

Sikder et al., 2003: Sikder, H. A., Devlin, M. K., Dunlap, S., Ryu, B. & Alani, R. M. Id proteins in cell growth and tumorigenesis. Cancer Cell, 3, 525–530, 2003.

Sobrero & Bruzzi, 2005: Sobrero, A. & Bruzzi, P. Bevacizumab Plus Fluorouracil: The Value of Being Part of a Developing Story. J. Clin. Oncol., 23, 1–3, 2005.

Spain et al., 1996: Spain, B. H., Bowdish, K. S., Pacal, A. R., Staub, S. F., Koo, D., Chang, C.-Y., Xie, W., & Colicelli, J. Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells. Mol. Cell. Biol., 16, 6698–6706, 1996.

Sreejayan & Rao, 1994: Sreejayan und Rao, M. N. Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol., 46, 1013–1016, 1994.

Street et al., 2002: Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F. V. Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J. L., Daugherty, A., van Bruggen, N., Redmond, H. P., Carano, R. A. & Filvaroff, E. H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. USA, 99, 9656–9661, 2002.

Sun et al., 1991: Sun, X-H., Copeland, N. G., Jenkins, N. & Baltimore, D. ID proteins, ID1 and ID2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol. Cell Biol., 11, 5603–5611, 1991.

Sun et al., 2002: Sun, Y., Wilson, M.P. & Majerus, P.W. Inositol 1 ,3,4 -trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1. J. Biol. Chem., 277, 45759–45764, 2002.

Sunwoo et al., 2001: Sunwoo, J. B., Chen, Z., Dong, G., Yeh, N., Bancroft, C. C., Sausville, E., Adams, J., Elliott, P. & Van Waes, C. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res., 7, 1419–1428, 2001.

Suzuki et al., 2002: Suzuki, G., Yanagawa, Y., Kwok, S. F., Matsui, M. & Deng, X. W. Arabidopsis COP10 is an ubiquitin-conjugating enzyme variant that acts together with COP1 and the COP9 signalosome in repressing photomorphogenesis. Genes & Dev., 16, 554–559, 2002.

Tanaka et al., 2001: Tanaka, K., Kawakami, T., Tateishi, K., Yashiroda, H. & Chiba, T. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie, 83, 351–356, 2001.

Tomoda et al., 1999: Tomoda, K., Kubota, Y. & Kato, J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature, 398, 160–165, 1999.

Tournay & Benezra, 1996: Tournay, O. & Benezra, R. Transcription of the dominant negative helix-loop-helix protein ID1 is regulated by a protein complex containing the immediate early response gene, Egr-1. Mol. Cell Biol., 16, 2418–2430, 1996.

Treier et al., 1994: Treier, M., Staszewski, L. M. & Bohmann, D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell, 78, 787–798, 1994.

Tsuge et al., 2001: Tsuge, T., Matsui, M .& Wei, N. The subunit 1 of the COP9 signalosome suppresses gene expression through its N-terminal domain and incorporates into the complex through the PCI domain. J. Mol. Biol., 305, 1–9, 2001.

Uhle et al., 2003: Uhle, S., Medalia, O., Waldron, R., Dumdey, R., Henklein, P., Bech-Otschir, D., Huang, X., Berse, M., Sperling, J., Schade, R. & Dubiel, W. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J., 22, 1302–1312, 2003.

van Dam & Castellazzi, 2001: van Dam, H. & Castellazzi, M. Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene, 20, 2453–2464, 2001.

Van Lint et al., 2002: Van Lint, J., Rykx, A., Maeda, Y., Vantus, T., Sturany, S., Malhotra, V., Vandenheede, J. R. & Seufferlein, T. Protein kinase D: an intracellular traffic regulator on the move. Trends Cell. Biol., 12, 193–200, 2002.

van Straaten et al., 1983: van Straaten, F., Muller, R., Curran, T., VanBeveren, C. & Verma, I. M. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc. Natl. Acad. Sci. USA, 80, 3183–3187, 1983.

Volpert et al., 2002: Volpert, O. V., Pili, R., Sikder, H. A., Nelius, T., Zaichuk, T., Morris, C., Shiflett, C. B., Devlin, M. K., Conant, K. & Alani, R.M. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell, 2, 473–483, 2002.

von Arnim, 2003: von Arnim, A. G. On again - off again: COP9 signalosome turns the key on protein degradation. Curr. Op. Plant Cell, 6, 520–529, 2003.

Wei & Deng, 1999: Wei, N. & Deng, X.-W. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis tu human. Trends Genet., 15, 98–103, 1999.

Wei et al., 1994: Wei, N., Chamovitz, D.A. & Deng, X.W. Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development. Cell, 78, 117–124, 1994.

Wei et al., 1998: Wei, N., Tsuge, T., Serino, G., Dohmae, N., Takio, K., Matsui, M. & Deng, X.W. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol., 8, 919–922, 1998.

Wernert et al., 1999: Wernert, N., Stanjek, A., Kiriakidis, S., Hügel, A., Jha, H. C., Mazitschek, R. & Giannis, A. Inhibierung der Angiogenese in vivo durch ets-1-Antisense-Oligonucleotide - Hemmung der Expression des Ets-1-Transkriptionsfaktors durch das Antibiotikum Fumagillin. Angew. Chem. 1999, 111,, 111, 3432–3435, 1999.

Wertz et al., 2004: Wertz, I. E., O'Rourke, K. M., Zhang, Z., Dornan, D., Arnott, D., Deshaies, R. J. & Dixit, V. M. Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase. Science, 303, 1371–1374, 2004.

Wibley et al., 1996: Wibley, J., Deed, R., Jasiok, M., Douglas, K. & Norton, J. A homology model of the Id-3 helix-loop-helix domain as a basis for structure-function predictions. Biochim. Biophys. Acta., 1294, 138–146, 1996.

Wilson et al., 2001: Wilson, M.P., Sun, Y., Cao, L. & Majerus, P.W. Inositol 1,3,4-trisphosphate 5/6-kinase is a protein kinase that phosphorylates the transcription factors c-Jun and ATF-2. J. Biol. Chem., 276, 40998–41004, 2001.

Winter et al., 2004: Winter, M., Milne, D., Dias, S., Kulikov, R., Knippschild, U., Blattner, C. & Meek, D. Protein kinase CK1delta phosphorylates key sites in the acidic domain of murine double-minute clone 2 protein (MDM2) that regulate p53 turnover. Biochemistry, 43, 16356–16364, 2004.

Wolf et al., 2003: Wolf, D. A., Zhou, C. & Wee, S. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases ?. Nat. Cell Biol., 5, 1029–1033, 2003.

Yamamoto et al., 2005: Yamamoto, A., Friedlein, A., Imai, Y., Takahashi, R., Kahle, P. J. & Haass, C. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J. Biol. Chem., 280, 3390–3399, 2005.

Yang et al., 2003: Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X. & Rosenberg, S. A. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med., 349, 427–434, 2003.

Yates et al., 1999: Yates, P. R., Atherton, G. T., Deed, R. W., Norton, J. D. & Sharrocks, A. D. ID helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF-ETS domain transcription factors. EMBO J., 18, 968–976, 1999.

Yokota, 2001: Yokota, Y. Id and development. Oncogene, 20, 8290–8298, 2001.

Yokota et al., 1999: Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S. & Gruss, P. Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2. Nature, 397, 702–706, 1999.

Zandomeni, 1989: Zandomeni, R.O. Kinetics of inhibition by 5 ,6 -dichloro-1-beta-Dribofuranosylbenzimidazole on calf thymus casein kinase II. Biochem. J., 262, 469–473, 1989.

Zhang et al., 1995: Zhang, L., Chang, C. J., Bacus, S. S. & Hung, M. C. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res., 55, 3890–3896, 1995.

Zhou et al., 2003: Zhou, C., Wee, S., Rhee, E., Naumann, M., Dubiel, W. & Wolf, D. A. Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. Mol. Cell., 11, 927–938, 2003.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: